XU CHEN: Open Payments
NPI 1841410503 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,184 in 77 payments from 5 companies in 2025. Trend: 2023 $1,399 · 2024 $1,130 · 2025 $1,184
Food & beverage: $1,184
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 47 | $480 |
| Alkermes, Inc. | 8 | $272 |
| Otsuka America Pharmaceutical, Inc. | 10 | $191 |
| Lundbeck LLC | 9 | $162 |
| Vanda Pharmaceuticals Inc. | 3 | $79 |
Products named: UZEDY, ARISTADA, ABILIFY ASIMTUFII, REXULTI, LYBALVI, AUSTEDO XR, ABILIFY MAINTENA, FANAPT.
Industry payments across NY — which companies pay providers there.
